NCT02136017View on ClinicalTrials.gov

Post-License Safety Evaluation of Influenza Virus Vaccine

CompletedOBSERVATIONAL
Enrollment

400,000

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
InfluenzaAdverse Drug Event
All Listed Sponsors
collaborator

China National Biotec Group Company Limited

INDUSTRY

lead

Sichuan Center for Disease Control and Prevention

OTHER_GOV

NCT02136017 - Post-License Safety Evaluation of Influenza Virus Vaccine | Biotech Hunter | Biotech Hunter